{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:22:08Z","timestamp":1793143328263,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.vaccine.2021.01.002","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T08:47:39Z","timestamp":1611046059000},"page":"1101-1110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines"],"prefix":"10.1016","volume":"39","author":[{"given":"Rebecca L.","family":"Brocato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Kwilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Josleyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiankun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey C.","family":"Perley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia M.","family":"Principe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Somerville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie V.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.01.002_b0005","series-title":"Fields Virology","first-page":"1741","article-title":"Bunyaviridae","author":"Nichol","year":"2006"},{"key":"10.1016\/j.vaccine.2021.01.002_b0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0046-8177(95)90123-X","article-title":"Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent","volume":"26","author":"Nolte","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.vaccine.2021.01.002_b0015","first-page":"552","article-title":"Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease","volume":"146","author":"Zaki","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2021.01.002_b0020","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3201\/eid1707.101306","article-title":"Hantavirus pulmonary syndrome, United States, 1993\u20132009","volume":"17","author":"MacNeil","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.002_b0025","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3201\/eid0911.020798","article-title":"Hantavirus pulmonary syndrome, southern Chile","volume":"9","author":"Riquelme","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.002_b0030","first-page":"30","article-title":"a short review","volume":"127","author":"Hantaviruses","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.vaccine.2021.01.002_b0035","series-title":"New Generation Vaccines","first-page":"905","article-title":"Hantavirus vaccines","author":"Hammerbeck","year":"2010"},{"key":"10.1016\/j.vaccine.2021.01.002_b0040","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1128\/JVI.77.18.9894-9905.2003","article-title":"Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine","volume":"77","author":"Custer","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.01.002_b0045","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1016\/j.vaccine.2013.07.025","article-title":"A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)","volume":"31","author":"Hooper","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.002_b0050","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/JVI.75.18.8469-8477.2001","article-title":"DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys","volume":"75","author":"Hooper","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.01.002_b0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1128\/CVI.00546-12","article-title":"Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine","volume":"20","author":"Brocato","year":"2013","journal-title":"Clin Vacc Immunol CVI"},{"key":"10.1016\/j.vaccine.2021.01.002_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.00832","article-title":"Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal Models","volume":"11","author":"Perley","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2021.01.002_b0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/viro.1998.9586","article-title":"DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection","volume":"255","author":"Hooper","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.01.002_b0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virol.2005.11.035","article-title":"Hantaan\/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates","volume":"347","author":"Hooper","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.01.002_b0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1566523214666140522122633","article-title":"A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates","volume":"14","author":"Kwilas","year":"2014","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.vaccine.2021.01.002_b0080","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.vaccine.2012.01.024","article-title":"A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome","volume":"30","author":"Boudreau","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2021.01.002_b0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/1469-0691.12553","article-title":"A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation","volume":"20","author":"Hooper","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2021.01.002_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/v11070610","article-title":"Progress on the Prevention and Treatment of Hantavirus Disease","volume":"11","author":"Brocato","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2021.01.002_b0095","article-title":"Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses","volume":"2015","author":"Golden","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2021.01.002_b0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/viro.2001.1133","article-title":"A lethal disease model for hantavirus pulmonary syndrome","volume":"289","author":"Hooper","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.01.002_b0105","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1006\/viro.1995.1019","article-title":"Isolation and initial characterization of a newfound hantavirus from California","volume":"206","author":"Schmaljohn","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.01.002_b0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7883\/yoken1952.36.17","article-title":"Isolation of virus causing hemorrhagic fever with renal syndrome (HFRS) through a cell culture system","volume":"36","author":"Kitamura","year":"1983","journal-title":"Jpn J Med Sci Biol"},{"key":"10.1016\/j.vaccine.2021.01.002_b0115","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jviromet.2009.11.004","article-title":"Study of Andes virus entry and neutralization using a pseudovirion system","volume":"163","author":"Ray","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2021.01.002_b0120","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1128\/jcm.35.5.1122-1130.1997","article-title":"Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes","volume":"35","author":"Elgh","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2021.01.002_b0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1586\/14760584.1.3.373","article-title":"Vaccines against hantaviruses","volume":"1","author":"Hjelle","year":"2002","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.01.002_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003803","article-title":"Antiviral Biologic Produced in DNA Vaccine\/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure","volume":"9","author":"Haese","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2021.01.002_b0135","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.01.002_b0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12985-016-0599-y","article-title":"Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickens","volume":"13","author":"Stachyra","year":"2016","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2021.01.002_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028757","article-title":"Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.01.002_b0150","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1038\/s41598-018-26281-z","article-title":"Codon optimization and improved delivery\/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity","volume":"8","author":"Latanova","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.01.002_b0155","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1128\/JVI.75.22.10991-11001.2001","article-title":"Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein","volume":"75","author":"Deml","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.01.002_b0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2013.12.020","article-title":"DNA vaccines for HFRS: laboratory and clinical studies","volume":"187","author":"Schmaljohn","year":"2014","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2021.01.002_b0165","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1016\/j.vaccine.2008.03.097","article-title":"Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters","volume":"26","author":"Spik","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.002_b0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular mechanisms for enhanced DNA vaccine immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:51:24Z","timestamp":1759402284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0264410X21000025"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.002","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.09.374439","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}